Cargando…
Ion Channel and Neurotransmitter Modulators as Electroceutical Approaches to the Control of Cancer
The activities of individual cells must be tightly coordinated in order to build and maintain complex 3-dimensional body structures during embryogenesis and regeneration. Thus, one way to view cancer is within systems biology as a network disorder affecting the ability of cells to properly interact...
Autores principales: | Tuszynski, Jack, Tilli, Tatiana M., Levin, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340161/ https://www.ncbi.nlm.nih.gov/pubmed/28554310 http://dx.doi.org/10.2174/1381612823666170530105837 |
Ejemplares similares
-
EDEn–Electroceutical Design Environment: Ion Channel Tissue Expression Database with Small Molecule Modulators
por: Churchill, Cassandra D.M., et al.
Publicado: (2018) -
Ion Channel Drugs Suppress Cancer Phenotype in NG108-15 and U87 Cells: Toward Novel Electroceuticals for Glioblastoma
por: Mathews, Juanita, et al.
Publicado: (2022) -
A Computational Strategy to Select Optimized Protein Targets for Drug Development toward the Control of Cancer Diseases
por: Carels, Nicolas, et al.
Publicado: (2015) -
Electroceuticals for Neurogastroenterology and Motility Disorders
por: Jiang, Yan, et al.
Publicado: (2023) -
Electroceuticals for peripheral nerve regeneration
por: Maeng, Woo-Youl, et al.
Publicado: (2022)